Collegium Pharmaceutical Inc (COLL) Expected Move

Tracking the COLL expected move helps you see how far Collegium Pharmaceutical Inc's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Collegium Pharmaceutical Inc's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the COLL expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For COLL, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The COLL expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Collegium Pharmaceutical Inc is unlikely to go.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc.

was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the COLL expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Collegium Pharmaceutical Inc expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about COLL.